Global Personalized Therapy Biosimulation Platform Market Research Report 2024

Publication ID:

PB509241567

Publication Date:

September 2, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Computing & Electronics [3]

Description:

Personalized Therapy Biosimulation refers to biosimulating a patient's unique cancer response to therapy prior to treatment and identifying new drug combinations for refractory patients. By utilizing this technology to determine a patient's Therapeutic Response Index, or TRI. TRIs in treatment-naive patients determine whether a patient will respond to standard-of-care treatments. For relapsed or refractory patients, TRIs identify the ideal combination of FDA-approved drugs that patients will respond to.
The global Personalized Therapy Biosimulation Platform market was valued at US$ 1394.3 million in 2023 and is anticipated to reach US$ 3619.6 million by 2030, witnessing a CAGR of 14.6% during the forecast period 2024-2030.
Increasing prevalence of malignancies and cancers, rising demand for biologics and biopharmaceuticals, high failure rate of clinical trials and high incidence of drug resistance are the key factors driving the growth of biomimetic personalized therapy market revenue.
This report aims to provide a comprehensive presentation of the global market for Personalized Therapy Biosimulation Platform, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Personalized Therapy Biosimulation Platform.
Report Scope
The Personalized Therapy Biosimulation Platform market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Personalized Therapy Biosimulation Platform market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Personalized Therapy Biosimulation Platform companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Cellworks Group
Certara
Simulation Plus
Schrodinger
In Silico Biosciences
Genedata
Physiomics
Insilico Biotechology
Chemical Computing Group ULC(CCG)
Evidera
AnyLogic
Shanghai Lide
Segment by Type
Pharmacokinetic
Pharmacoeconomics
Segment by Application
Pharmaceutical and Biotech Companies
Research Institutions
Hospital
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Personalized Therapy Biosimulation Platform companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Personalized Therapy Biosimulation Platform Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Pharmacokinetic
1.2.3 Pharmacoeconomics
1.3 Market by Application
1.3.1 Global Personalized Therapy Biosimulation Platform Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical and Biotech Companies
1.3.3 Research Institutions
1.3.4 Hospital
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Personalized Therapy Biosimulation Platform Market Perspective (2019-2030)
2.2 Personalized Therapy Biosimulation Platform Growth Trends by Region
2.2.1 Global Personalized Therapy Biosimulation Platform Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Personalized Therapy Biosimulation Platform Historic Market Size by Region (2019-2024)
2.2.3 Personalized Therapy Biosimulation Platform Forecasted Market Size by Region (2025-2030)
2.3 Personalized Therapy Biosimulation Platform Market Dynamics
2.3.1 Personalized Therapy Biosimulation Platform Industry Trends
2.3.2 Personalized Therapy Biosimulation Platform Market Drivers
2.3.3 Personalized Therapy Biosimulation Platform Market Challenges
2.3.4 Personalized Therapy Biosimulation Platform Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Personalized Therapy Biosimulation Platform Players by Revenue
3.1.1 Global Top Personalized Therapy Biosimulation Platform Players by Revenue (2019-2024)
3.1.2 Global Personalized Therapy Biosimulation Platform Revenue Market Share by Players (2019-2024)
3.2 Global Personalized Therapy Biosimulation Platform Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Personalized Therapy Biosimulation Platform Revenue
3.4 Global Personalized Therapy Biosimulation Platform Market Concentration Ratio
3.4.1 Global Personalized Therapy Biosimulation Platform Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Personalized Therapy Biosimulation Platform Revenue in 2023
3.5 Personalized Therapy Biosimulation Platform Key Players Head office and Area Served
3.6 Key Players Personalized Therapy Biosimulation Platform Product Solution and Service
3.7 Date of Enter into Personalized Therapy Biosimulation Platform Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Personalized Therapy Biosimulation Platform Breakdown Data by Type
4.1 Global Personalized Therapy Biosimulation Platform Historic Market Size by Type (2019-2024)
4.2 Global Personalized Therapy Biosimulation Platform Forecasted Market Size by Type (2025-2030)
5 Personalized Therapy Biosimulation Platform Breakdown Data by Application
5.1 Global Personalized Therapy Biosimulation Platform Historic Market Size by Application (2019-2024)
5.2 Global Personalized Therapy Biosimulation Platform Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Personalized Therapy Biosimulation Platform Market Size (2019-2030)
6.2 North America Personalized Therapy Biosimulation Platform Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Personalized Therapy Biosimulation Platform Market Size by Country (2019-2024)
6.4 North America Personalized Therapy Biosimulation Platform Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Personalized Therapy Biosimulation Platform Market Size (2019-2030)
7.2 Europe Personalized Therapy Biosimulation Platform Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Personalized Therapy Biosimulation Platform Market Size by Country (2019-2024)
7.4 Europe Personalized Therapy Biosimulation Platform Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Personalized Therapy Biosimulation Platform Market Size (2019-2030)
8.2 Asia-Pacific Personalized Therapy Biosimulation Platform Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Personalized Therapy Biosimulation Platform Market Size by Region (2019-2024)
8.4 Asia-Pacific Personalized Therapy Biosimulation Platform Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Personalized Therapy Biosimulation Platform Market Size (2019-2030)
9.2 Latin America Personalized Therapy Biosimulation Platform Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Personalized Therapy Biosimulation Platform Market Size by Country (2019-2024)
9.4 Latin America Personalized Therapy Biosimulation Platform Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Personalized Therapy Biosimulation Platform Market Size (2019-2030)
10.2 Middle East & Africa Personalized Therapy Biosimulation Platform Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Personalized Therapy Biosimulation Platform Market Size by Country (2019-2024)
10.4 Middle East & Africa Personalized Therapy Biosimulation Platform Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cellworks Group
11.1.1 Cellworks Group Company Detail
11.1.2 Cellworks Group Business Overview
11.1.3 Cellworks Group Personalized Therapy Biosimulation Platform Introduction
11.1.4 Cellworks Group Revenue in Personalized Therapy Biosimulation Platform Business (2019-2024)
11.1.5 Cellworks Group Recent Development
11.2 Certara
11.2.1 Certara Company Detail
11.2.2 Certara Business Overview
11.2.3 Certara Personalized Therapy Biosimulation Platform Introduction
11.2.4 Certara Revenue in Personalized Therapy Biosimulation Platform Business (2019-2024)
11.2.5 Certara Recent Development
11.3 Simulation Plus
11.3.1 Simulation Plus Company Detail
11.3.2 Simulation Plus Business Overview
11.3.3 Simulation Plus Personalized Therapy Biosimulation Platform Introduction
11.3.4 Simulation Plus Revenue in Personalized Therapy Biosimulation Platform Business (2019-2024)
11.3.5 Simulation Plus Recent Development
11.4 Schrodinger
11.4.1 Schrodinger Company Detail
11.4.2 Schrodinger Business Overview
11.4.3 Schrodinger Personalized Therapy Biosimulation Platform Introduction
11.4.4 Schrodinger Revenue in Personalized Therapy Biosimulation Platform Business (2019-2024)
11.4.5 Schrodinger Recent Development
11.5 In Silico Biosciences
11.5.1 In Silico Biosciences Company Detail
11.5.2 In Silico Biosciences Business Overview
11.5.3 In Silico Biosciences Personalized Therapy Biosimulation Platform Introduction
11.5.4 In Silico Biosciences Revenue in Personalized Therapy Biosimulation Platform Business (2019-2024)
11.5.5 In Silico Biosciences Recent Development
11.6 Genedata
11.6.1 Genedata Company Detail
11.6.2 Genedata Business Overview
11.6.3 Genedata Personalized Therapy Biosimulation Platform Introduction
11.6.4 Genedata Revenue in Personalized Therapy Biosimulation Platform Business (2019-2024)
11.6.5 Genedata Recent Development
11.7 Physiomics
11.7.1 Physiomics Company Detail
11.7.2 Physiomics Business Overview
11.7.3 Physiomics Personalized Therapy Biosimulation Platform Introduction
11.7.4 Physiomics Revenue in Personalized Therapy Biosimulation Platform Business (2019-2024)
11.7.5 Physiomics Recent Development
11.8 Insilico Biotechology
11.8.1 Insilico Biotechology Company Detail
11.8.2 Insilico Biotechology Business Overview
11.8.3 Insilico Biotechology Personalized Therapy Biosimulation Platform Introduction
11.8.4 Insilico Biotechology Revenue in Personalized Therapy Biosimulation Platform Business (2019-2024)
11.8.5 Insilico Biotechology Recent Development
11.9 Chemical Computing Group ULC(CCG)
11.9.1 Chemical Computing Group ULC(CCG) Company Detail
11.9.2 Chemical Computing Group ULC(CCG) Business Overview
11.9.3 Chemical Computing Group ULC(CCG) Personalized Therapy Biosimulation Platform Introduction
11.9.4 Chemical Computing Group ULC(CCG) Revenue in Personalized Therapy Biosimulation Platform Business (2019-2024)
11.9.5 Chemical Computing Group ULC(CCG) Recent Development
11.10 Evidera
11.10.1 Evidera Company Detail
11.10.2 Evidera Business Overview
11.10.3 Evidera Personalized Therapy Biosimulation Platform Introduction
11.10.4 Evidera Revenue in Personalized Therapy Biosimulation Platform Business (2019-2024)
11.10.5 Evidera Recent Development
11.11 AnyLogic
11.11.1 AnyLogic Company Detail
11.11.2 AnyLogic Business Overview
11.11.3 AnyLogic Personalized Therapy Biosimulation Platform Introduction
11.11.4 AnyLogic Revenue in Personalized Therapy Biosimulation Platform Business (2019-2024)
11.11.5 AnyLogic Recent Development
11.12 Shanghai Lide
11.12.1 Shanghai Lide Company Detail
11.12.2 Shanghai Lide Business Overview
11.12.3 Shanghai Lide Personalized Therapy Biosimulation Platform Introduction
11.12.4 Shanghai Lide Revenue in Personalized Therapy Biosimulation Platform Business (2019-2024)
11.12.5 Shanghai Lide Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Cellworks Group
Certara
Simulation Plus
Schrodinger
In Silico Biosciences
Genedata
Physiomics
Insilico Biotechology
Chemical Computing Group ULC(CCG)
Evidera
AnyLogic
Shanghai Lide

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂